Skip to main content
PureTech Health plc logo

PureTech Health plc — Investor Relations & Filings

Ticker · PRTC ISIN · GB00BPVG5C82 LEI · 213800LVPDNO2Z9T9I39 IL Manufacturing
Filings indexed 1,320 across all filing types
Latest filing 2022-06-01 Transaction in Own Shar…
Country GB United Kingdom
Listing IL PRTC

About PureTech Health plc

https://puretechhealth.com/

PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is titled 'Transaction in Own Shares' and details the purchase of ordinary shares by PureTech Health PLC as part of its 'Share Buyback Programme'. It provides specific transaction dates (31 May 2022), volumes, and prices. This activity directly corresponds to the definition of a company buying back or selling its own shares, which maps to the 'Transaction in Own Shares' category. This matches the definition for Code: POS (Transaction in Own Shares).
2022-06-01 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an RNS announcement (indicated by 'RNS Number : 2958N') from PureTech Health PLC, dated May 31, 2022. The title explicitly states 'Transaction in Own Shares' and details the purchase of ordinary shares as part of a 'Share Buyback Programme'. This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). Although it is an RNS filing, the content is highly specific to share repurchase activity, making POS a more precise classification than the general RNS fallback.
2022-05-31 English
Transaction in Own Shares
Transaction in Own Shares Classification · 99% confidence The document is an RNS announcement from PureTech Health PLC dated May 30, 2022. The title explicitly states 'Transaction in Own Shares'. The content details the purchase of ordinary shares as part of a 'Share Buyback Programme' and provides specific transaction data (date, volume, price). This directly corresponds to the definition of 'Transaction in Own Shares', which maps to the filing type code POS (Report of the company buying back or selling its own shares (share repurchase/issuance)). The document is not a general regulatory filing (RNS) because it fits a more specific category, nor is it an announcement of a report (RPA) as it contains the substantive transaction details.
2022-05-30 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is titled 'Transaction in Own Shares' and explicitly details the purchase of ordinary shares as part of a 'Share Buyback Programme'. It provides specific transaction dates, volumes, and prices. This directly corresponds to the definition of 'Transaction in Own Shares', which maps to the filing type code POS (Report of the company buying back or selling its own shares (share repurchase/issuance)). The RNS Number format also suggests a regulatory disclosure related to share capital changes.
2022-05-27 English
Akili & Roblox (NYSE:RBLX) Partner on EndeavorRx
Regulatory Filings Classification · 100% confidence The document starts with an RNS Number (8405M) and a date, indicating it is a regulatory or news announcement. The content describes a collaboration between PureTech Health's founded entity, Akili, and Roblox regarding a prescription video game treatment (EndeavorRx®). This type of announcement, detailing a business development, partnership, or significant operational update that is not a formal financial report (like 10-K or IR) or a specific corporate action (like DIV or SHA), typically falls under general regulatory announcements or press releases distributed via services like RNS. Since the document explicitly mentions it is provided by 'Reach, the non-regulatory press release distribution service of RNS,' and it is a general business update, the most appropriate classification is Regulatory Filings (RNS), which serves as the general category for such announcements not covered by more specific codes.
2022-05-26 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states the subject is 'Transaction in Own Shares' and details the purchase of ordinary shares as part of a 'Share Buyback Programme'. It provides specific transaction dates, volumes, and prices. This directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers the company buying back its own shares.
2022-05-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.